LIGAND
Live / Applied — Second extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 12 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98354886
- Mark type
- Design + words
- Filed
- 12 Jan 2024
- Published for opposition
- 24 Sept 2024
- Attorney of record
- Gazal Pour-Moezzi
Goods and services
- Class 001 — Chemicals: Solubilizing chemical agents for use in the manufacture of pharmaceutical preparations; Solubilizing chemical agents for use in diagnostic research
- Class 005 — Pharmaceuticals: Antivirals
Owner
- Ligand Pharmaceuticals Incorporated, Jupiter, FL, US
- Ligand Pharmaceuticals Incorporated, San Diego, CA, US
Prior registrations
Prosecution history
- 12 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 2 GRANTED
- 10 Nov 2025 — SOU EXTENSION 2 FILED
- 11 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 27 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2025 — CORRECTED NOA E-MAILED
- 24 Oct 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Oct 2025 — SOU EXTENSION 1 GRANTED
- 13 May 2025 — SOU EXTENSION 1 FILED
- 24 Oct 2025 — DIVISIONAL PROCESSING COMPLETE
- 14 May 2025 — DIVISIONAL REQUEST RECEIVED
- 30 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Aug 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 26 Aug 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED